Caliway Biopharmaceuticals Co., Ltd.
Clinical trials sponsored by Caliway Biopharmaceuticals Co., Ltd., explained in plain language.
A Taiwan-based biopharmaceutical company developing treatments for inflammatory and fibrotic diseases.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
New injection aims to smooth cellulite dimples
Symptom relief CompletedThis study tests an investigational drug called CBL-514, given as an injection into areas of cellulite on the thighs. The goal is to see if it can safely reduce the severity of cellulite dimpling. The trial involves women aged 18 to 64 with mild to moderate cellulite. Researchers…
Phase: PHASE2 • Sponsor: Caliway Biopharmaceuticals Co., Ltd. • Aim: Symptom relief
Last updated Jul 11, 2026 00:00 UTC
-
New Fat-Targeting drug tested in healthy volunteers
Knowledge-focused CompletedThis study tested a single injection of CBL-514 in 10 healthy volunteers to see how the body processes it and whether it is safe. Researchers measured drug levels in the blood and monitored for side effects. The goal was to gather basic safety and drug behavior information, not t…
Phase: PHASE2 • Sponsor: Caliway Biopharmaceuticals Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC